Bayer Result, Hensoldt Falls, Anglo American's Failed Deal - podcast episode cover

Bayer Result, Hensoldt Falls, Anglo American's Failed Deal

Nov 24, 20255 min
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

On this episode of Stock Movers:
- Bayer said an experimental stroke-prevention drug showed positive results in a late-stage study, a boost for the German company as it seeks to counter sales declines from aging blockbuster medicines.
- Hensoldt and other European defense shares are on watch over the latest news around Ukraine
- BHP Group has walked away from a fresh takeover approach for Anglo American Plc, ending an unexpected and short-lived attempt by the world’s largest miner to thwart a planned tie-up between its smaller rival and Canada’s Teck Resources Ltd.

See omnystudio.com/listener for privacy information.

Transcript

Speaker 1

Bloomberg Audio Studios, podcasts, radio News, The.

Speaker 2

Stock Movers Report, your roundup of companies making moves in the stock market, harnessing the power of Bloomberg Data.

Speaker 3

Let's look at some of the stocks on the move today here in Europe. I'm Caroline hep Go alongside Tom McKenzie, and we're joined by Bloomberger Paul to Chloe Malay. Good morning, Chloe. Let's firstly look at Bayer looking at a promising drug trial. What's happened there.

Speaker 4

Yeah, so they're experimental stroke prevention drug showed very positive results in clinical study, so that's a big boost for the company after a lot of troubles recently. Of course, they're still dealing with ongoing litigation over their roundup weed killer, and then also they have been seeing declining sales of some of its key blockbuster drugs that are facing a

growing generic competition. So importantly, this particular stroke prevention drug is not increasing the risk of major bleeding, which is usually the problem that arises with blood thinning medicines like these. So it's a big win because some of the other competitors have really not managed to make any major inroads in this particular in this particular part of medicine. So earlier this month we have seen results from a Bristol Meyers squib and Johnson and Johnson which really created doubt

about this particular class of medicines. They had to hold a trial because one of the drugs that they were trying out appeared really unlikely to help patients who had suffered a heart complication. So definitely a big boost for buyer who seems to be making those inroads while the competitors are staying behind.

Speaker 1

The defense spaces and focus because there's a lot of anticipation speculation that maybe there will be progress in the US Secretor of State has suggested there has been progressed in terms of talks with Ukraine about getting to some kind of deal with Russia, with all sorts of question marks that still need to be asked as of course and cleared up into the detail. But you're being defense docs are as a result in focus, what's happening with Henshalt in particular.

Speaker 4

Yeah, hensold, Ryan, mattau Rank, all of those companies were down this morning. So we have seen, as you mentioned, a little bit of progress on the peace front for Ukraine, and therefore we are seeing those names down kind of across the board this morning. So last week we actually had the beginning of this with Chares falling after Zelenski said that he agreed to work on a peace plan

that was drafted by the US and Russia. And today we have got those downward movements again because of the upcoming meeting between the US and Ukraine, and that meeting will be held within the next week or maybe the week after to discuss Ukraine's native membership and also exchange of territories. Some negotiations have already taken place on Sunday and Ukrainian American delegations have agreed on some of the items or adjusted some of the items of the plan,

including the size of the Ukraine and army. And as you said, there's still a lot of details to be worked out. But as always, a peace is not great business for defense companies and they tend to for when there is progress on that on that front.

Speaker 3

Hmm. Okay, So that's in the defense space. What about mining, So there's been a kind of short lived bit of m and a news that has been unraveled today. Explain that one for US.

Speaker 4

Yeah, busy weekend in the mining m and A sector. So Anglo American was approached by BHP once again, and then Anglo American rejected that bid, and BHP has now walked away fully from that deal, and so Anglo American shares yoyed a little bit this morning as investors try and kind of digest what's happening there on this M and A story. So this was an attempt by BHP to a thwart a plan tire between Anglo American and Tech Resources, and that also follows a failed bid for

Anglo American that we remember from last year. So now we are back with this data squore. Really, but this speaks to pressures in an industry where those companies really want to add a lot of scale of growth, especially in copper, because that is a material that is crucial to the world's electrification and both Anglo Marrita and Tech Resources are very copper rich, and they're about to vote in just a few weeks on a deal to create a company that is that will be worth more than

sixty billion dollars. So that explains why BHP wants to try again, but it's not worked out for them.

Speaker 2

The stock Movers report from Bloomberg Radio check Back with us throughout the day for the latest roundup of companies making news on Wall Street, and for the latest market moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube, Bloomberg dot com, and on Applecarplay and Android Auto with the Bloomberg Business app.

Transcript source: Provided by creator in RSS feed: download file
For the best experience, listen in Metacast app for iOS or Android